Release Date: 28/11/12 13:14 Summary: Release of Escrowed Shares Price Sensitive: No Download Document 274.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%